INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
INVO Bioscience Inc (INVO) - Total Liabilities
Latest total liabilities as of September 2024: $17.04 Million USD
Based on the latest financial reports, INVO Bioscience Inc (INVO) has total liabilities worth $17.04 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
INVO Bioscience Inc - Total Liabilities Trend (2006–2023)
This chart illustrates how INVO Bioscience Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
INVO Bioscience Inc Competitors by Total Liabilities
The table below lists competitors of INVO Bioscience Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EATON CORP -NPV-
MU:3EC
|
Germany | €20.07 Billion |
|
Delivra Health Brands Inc
OTCQB:DHBUF
|
USA | $4.76 Million |
|
Loyal Textile Mills Limited
NSE:LOYALTEX
|
India | ₹4.67 Billion |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
USA | $14.04 Million |
|
Joy Industrial Co., Ltd.
TWO:4559
|
Taiwan | NT$1.21 Billion |
|
LTI0
F:LTI0
|
Germany | €25.79 Million |
|
Sulliden Minerals SA
TO:SMC
|
Canada | CA$2.72 Million |
Liability Composition Analysis (2006–2023)
This chart breaks down INVO Bioscience Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -730.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INVO Bioscience Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INVO Bioscience Inc (2006–2023)
The table below shows the annual total liabilities of INVO Bioscience Inc from 2006 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $19.99 Million | +293.50% |
| 2022-12-31 | $5.08 Million | +61.02% |
| 2021-12-31 | $3.16 Million | -39.36% |
| 2020-12-31 | $5.20 Million | -5.53% |
| 2019-12-31 | $5.51 Million | +57.33% |
| 2018-12-31 | $3.50 Million | -33.41% |
| 2017-12-31 | $5.26 Million | +21.25% |
| 2016-12-31 | $4.34 Million | 0.00% |
| 2015-12-31 | $4.34 Million | -2.92% |
| 2014-12-31 | $4.47 Million | +13.45% |
| 2013-12-31 | $3.94 Million | +12.56% |
| 2012-12-31 | $3.50 Million | +14.57% |
| 2011-12-31 | $3.05 Million | +14.65% |
| 2010-12-31 | $2.66 Million | -24.46% |
| 2009-12-31 | $3.52 Million | +256.73% |
| 2008-12-31 | $988.12K | +44230.28% |
| 2007-12-31 | $2.23K | +791.60% |
| 2006-12-31 | $250.00 | -- |